Advisory Board and Editors Cell Biology

Journal Factsheet
A one-page PDF to help when considering journal options with co-authors
Download Factsheet
I told my colleagues that PeerJ is a journal where they need to publish if they want their paper to be published quickly and with the strict peer review expected from a good journal.
Sohath Vanegas,
PeerJ Author
View author feedback

Anne Fernandez

Research Director of the Centre National de la Recherche Scientifique (CNRS); Lab leader of the Mammalian Cell Biology Unit at the Institute for Human Genetics (IGH) of the CNRS and University of Montpellier.

Principal research themes: Post-translational control of cell division cycle from quiescence to proliferation and differentiation of progenitor cells and multipotent stem cells from adult skeletal muscle.

Alda Maria Ferreira

I have a master's degree in microbiology and PhD in Cellular and Molecular Biology. I am an Associate Professor of Immunology at the Federal University of Mato Grosso do Sul, Brazil. I have already supervised six master's and one doctoral students in the areas of biochemistry and infectious diseases.

My main area of interest is cellular and molecular biology of pathogens, infectious diseases and biological assays. So far I have published several papers involving studies in these areas.

I am the leader of a research group certified by the CNpQ (National Council for Scientific and Technological Development) on biological assays with >Trypanosoma cruzi<, which is the etiologic agent of Chagas disease.

Gian Maria Fimia

Professor of Cell and Developmental Biology, University of Salento, Italy
Principal Investigator at the National Institute for Infectious Diseases L. Spallanzani IRCCS (Rome, Italy)

Carla Fiorentini

CARLA FIORENTINI is presently Director of Preclinical Research at the Association for Research of Integrative Oncology Therapies (ARTOI). She was Director of “Natural Substances, Traditional Medicine” Section at the Dept. of Therapeutic Research and Medicines Evaluation, and Coordinator of a Research Group at the Italian Center for Global Health, Istituto Superiore di Sanità (ISS), Roma. Academic Degree in Biology and Specialty in Microbiology, University of Roma. Post-doctoral training at Karolinska Institutet, Stockholm, Sweden. Her current research is focused on unravelling the role of bacterial protein toxins in cancer and on the use the bacterial toxin CNF1 as a potential novel therapeutic for central nervous system disorders. She is co-inventor in five different patents on CNF1 activity on the central nervous system. As co-author of numerous book chapters and articles in leading journals, she is renowned in the field of bacterial protein toxins.

Suzanne M.J. Fleiszig

Professor, University of California, Berkeley. Programs in Optometry, Vision Science, Infectious Disease and Immunity, and Microbiology. Vice President, Tear Film and Ocular Surface Society. Former President, International Society for Contact Lens Research. Councillor, American Society for Microbiology. Recipient of the 2005 Glenn A. Fry Award and the 2010 Korb Award. Editorial Boards: PLoS ONE, Infection & Immunity, and Investigative Ophthalmology & Vision Science.

Mario Alberto Flores-Valdez

Dr. Mario Alberto Flores-Valdez is a Professor in the Medical and Pharmaceutical Biotechnology Unit, CIATEJ, A.C., Guadalajara, Jalisco, Mexico (2007-present). He is a member of the National System of Researchers (SNI), and a member of the Mexican Academy of Sciences. He was a Stanford University Medical Center postdoctoral fellow (2004-2007), where he received a Dean's Fellowship Award (2006) to conduct research on Tuberculosis. He worked in UNAM as Research Assistant for Prof. Jaime Mora (2004) and Prof. Emundo Calva (2003). He has received a Ph.D. in Biochemistry from UNAM (1999-2003), a M.Sc. in Molecular Biology and Genetic Engineering from UANL (1996-1999) and a B.Sc. from Universidad de Sonora (1991-1996) in Chemistry and Biology. He received fellowships from CONACYT for M.Sc. and Ph.D. studies and in M.Sc. and B.Sc. has received Diplomas as Best Student. He has expertise in Tuberculosis, particularly in developing recombinant BCG strains. He has been PI for 7 grants from 2008 to date, focused in studies about tuberculosis vaccine development and basic aspects of mycobacterial physiology.

Heike Folsch

Research Associate Professor at the Northwestern University, Feinberg School of Medicine, Department of Cell and Developmental Biology. Research fields include the investigation of membrane trafficking in polarized epithelial cells.

Puri Fortes

PhD in Biology at Autonoma University (Madrid) working with Dr. Juan Ortin (NS1 protein from influenza virus and RNA splicing, transport and translation).
Postdoc at EMBL-Heidelberg working with Dr. Iain Mattaj (nuclear cap binding complex and splicing, polyadenylation and translation).
PI at CIMA (U1 snRNP regulation, viral miRNAs, viral lncRNAs, gene therapy, liver diseases)

Tamas Fulop

Dr. Tamàs Fülöp is Assistant Director of the Age Research Centre and Full Professor within the Faculty of Medicine and Health Sciences at the Université de Sherbrooke in Quebec, Canada. He is also Head of the Immune Inflammation Laboratory and Medical Director of the Memory Clinic.

M.D: From the Unversity of Geneva.

His postdoctoral research was in the biochemistry of connective tissues, and his PhD is in immunology and gerontology. His research interest is aging in relation to immunity.

Brigitte Galliot

MD, PhD, Associate Professor at the Faculty of Science, Department of Genetics and Evolution, University of Geneva, Switzerland. Elected Vice-Dean. Member of Academia-net. Post-doctoral stage at the ZMBH, Heidelberg, Germany; PhD in Life Sciences in Strasbourg, France; medical studies in Paris, France. Since my post-doc time, I study the molecular and cellular basis of regeneration, neurogenesis and aging and I use Hydra, a freshwater cnidarian polyp, as model system.

Liang Gao

Dr. Liang Gao currently works as a senior Research Fellow at the Center of Experimental Orthopaedics, Saarland University, Germany. His clinical interests include sports medicine, arthroplasty, and traumatology. His research focuses on joint preservation and orthobiologics.

Dr. Gao studied Medicine in China and Germany with intensive fellowship training in both Asia and Europe. He completed the Musculoskeletal Surgical Oncology residency training at Peking University Medical Center, China. Moreover, he obtained his master of science degree (Radiation Oncology) from Heidelberg University, Germany and his doctorate (Biological Therapy) summa cum laude from Saarland University, Germany.

Dr. Gao is the Member of the Basic Science Committee of International Cartilage Regeneration & Joint Preservation Society (ICRS), the Member of the Early Career Investigator Committee of Osteoarthritis Research Society International (OARSI), and the Founding Member of the Sino Euro Orthopaedics Society (SEOS).

Shou-Jiang (SJ) Gao

Dr. Gao is a Professor and Director of the Cancer Virology Program at the Hillman Cancer Center and in the Department of Microbiology and Molecular Genetics in the University of Pittsburgh School of Medicine.

Dr. Gao is an Elected Fellow of the American Academy of Microbiology. He currently serves as the Editor-In-Chief for the Journal of Medical Virology, Section Editor for PLoS Pathogens, and Academic Editor for PLoS One and PeerJ. He is also serving on the Editorial Boards of over 10 peer-reviewed journals including Journal of Virology, Journal of Antivirals & Antiretrovirals, Journal of Molecular Biomarkers and Diagnosis, Journal of Microbial & Biochemical Technology, Sarcoma Research International, Oncolytic Virotherapy, etc.